Showing 2761–2772 of 3002 results

  • TRANSAMIN INJ 500MG NEW

    TRANSAMIN INJ 500MG NEW

    0 out of 5
    1,515.70

    TRANSAMIN (Tranexamic Acid) is an antifibrinolytic agent used to prevent or reduce excessive bleeding in various medical conditions such as surgery, trauma, heavy menstrual bleeding, or certain bleeding disorders. Active Ingredient: Tranexamic Acid 500 mg/mL Mechanism of Action: Inhibits plasminogen activation, preventing breakdown of fibrin clots Helps stabilize blood clots and control bleeding Key Benefits:…

  • TRAVATAN SOL 2.5ML NEW

    TRAVATAN SOL 2.5ML NEW

    0 out of 5
    1,854.29

    TRAVATAN Solution is an ophthalmic eye drop used for the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Active Ingredient: Travoprost 0.004% (40 mcg/mL) Travoprost belongs to the prostaglandin analog class and works by increasing the outflow of aqueous humor, thereby lowering intraocular pressure. Key Benefits: Reduces intraocular pressure…

  • TRAVOGEN 10GM CREAM

    TRAVOGEN 10GM CREAM

    0 out of 5
    176

    Travogen cream is an antifungal medicine used for skin infections like athlete’s foot and ringworm. It stops the growth of fungi on the skin. It also helps reduce itching, scaling, redness, and discomfort.

  • TRES ORIX FORTE 120ML SYP

    TRES ORIX FORTE 120ML SYP

    0 out of 5
    300

    Tres Orix Forte is an appetite stimulant syrup used to increase hunger. It helps people who are underweight or have lost appetite due to illness. It improves nutritional intake and supports healthy weight gain.

  • TREVIA 50MG TAB

    TREVIA 50MG TAB

    0 out of 5
    538

    Trevia 50mg contains sitagliptin, a medicine used for type 2 diabetes. It helps the body release more insulin and reduce blood sugar levels. It is taken daily to control diabetes and prevent long-term complications.

  • TREVIA R2 15/100MG TABLET

    TREVIA R2 15/100MG TABLET

    0 out of 5
    775

    TREVIA R2 15/100MG is a combination oral tablet used in the management of type 2 diabetes mellitus. It contains: 15 mg of an SGLT2 inhibitor 100 mg of a DPP-4 inhibitor This combination helps to control blood glucose levels by increasing urinary glucose excretion and improving insulin response. Key Benefits: Reduces high blood sugar in…

  • TREVIA R2 15/100MG TABLET

    TREVIA R2 15/100MG TABLET

    0 out of 5
    775
  • TREVIA R2 5/100MG TABLET

    TREVIA R2 5/100MG TABLET

    0 out of 5
    665

    Trevia R2 combines sitagliptin and metformin, used to control high blood sugar. It improves the body’s use of insulin and lowers sugar production by the liver. It helps prevent kidney, nerve, and heart problems caused by diabetes.

  • TREVIAMET 50/1000MG TAB (28s)

    TREVIAMET 50/1000MG TAB (28s)

    0 out of 5
    1,176

    Treviamet combines sitagliptin and metformin to manage type 2 diabetes. It controls blood sugar levels effectively throughout the day. It also lowers the risk of complications like nerve damage, kidney problems, and vision loss.

  • TREVIAMET 50/500MG TAB (28s)

    TREVIAMET 50/500MG TAB (28s)

    0 out of 5
    585

    Treviamet 50/850mg is a combination anti-diabetic medicine. It helps lower high blood sugar levels by improving insulin sensitivity. It is used along with diet and exercise in type 2 diabetes treatment.

  • TREVIAMET XR 100/1000MG TAB

    TREVIAMET XR 100/1000MG TAB

    0 out of 5
    770

    Treviamet XR is an extended-release tablet for type 2 diabetes. It gradually releases medicine to control blood sugar over 24 hours. It helps maintain steady sugar levels and prevents spikes.

  • TREVIAMET XR 50/1000MG TAB

    TREVIAMET XR 50/1000MG TAB

    0 out of 5
    670

    Treviamet XR 50/1000mg helps keep blood sugar levels under control all day. It is an extended-release form that works slowly and consistently. It is used in type 2 diabetes to reduce complications.

End of content

End of content

The Categories provide a framework to which existing art information systems can be mapped and upon which new systems can be developed. In addition, the discussions in the CDWA identify vocabulary resources and descriptive practices that will make information residing in diverse systems both more compatible and more accessible.The use of the CDWA framework will contribute to the integrity and longevity of data and will facilitate its inevitable migration to new systems as informational technology continues to evolve. Above all, it will help to give end-users consistent, reliable access to information, regardless of the system in which it resides.